# PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing

> **NCT03423264** · PHASE2 · WITHDRAWN · sponsor: **University of Chicago**

## Conditions studied

- Oropharyngeal Cancer
- HPV-Related Squamous Cell Carcinoma

## Interventions

- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT03423264
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-01-22
- **Primary completion:** 2022-11-08
- **Final completion:** 2022-11-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unable to accrue
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423264, "PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03423264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*